Background Single intrauterine fetal death affects approximately 6% of twin pregnancies and can have serious sequelae for the surviving co-twin.
Introduction
Twin pregnancies are associated with increased perinatal morbidity and mortality compared with singleton pregnancies. Single intrauterine fetal death (sIUFD) occurs in approximately 6% of twin pregnancies, making it a common adverse event.
1 Monochorionic (MC) twins with placental inter-twin anastomoses conjoining the fetal circulations are associated with an increased risk of sIUFD and consequential fetal morbidity. 2, 3 Many are first-trimester fetal losses, but sIUFD after 14 weeks' gestation is associated with the greatest adverse effect on the surviving fetus. 4 Morbid events associated with sIUFD in twin pregnancy include: co-twin IUFD, preterm birth (spontaneous or iatrogenic), and long-term comorbidity; most commonly ante-or postnatal brain injury. A critical appraisal and interpretation of the literature is complicated by significant heterogeneity in the incidence and management in reported studies. 5 In 2011, our group completed a systematic review and meta-analysis of co-twin prognosis following sIUFD, with outcomes stratified by chorionicity. In the 22 included manuscripts there were 343 cases of sIUFD reported in 6225 twin pregnancies. 6 A meta-analysis of event rates was not undertaken as there was a high risk of heterogeneity and low number of events within each study. A summary point estimate was produced with a simple binomial confidence interval, thus not allowing for the non-independence of the different studies. The previous article demonstrated an increased odds ratio of co-twin death and neurodevelopmental morbidity after sIUFD in MC compared with dichorionic (DC) twin pregnancies. The management of multiple pregnancies in general, particularly MC pregnancies, has received considerable attention since 2011, with national and international guidelines being published by professional bodies. [7] [8] [9] [10] [11] [12] Importantly, the 2011 review included twin pregnancies that had undergone intervention for twin-twin transfusion syndrome (TTTS) and fetal growth restriction (FGR) and thus confounding factors such as surgeon experience may have affected the reported prognosis. 13 This review will focus on spontaneous sIUFD only and will not include pregnancies that have undergone treatment for TTTS or FGR.
The objective of the study was to determine the prognosis of the surviving co-twin following spontaneous sIUFD. The outcomes explored were: co-twin IUFD, preterm birth (PTB), abnormal postnatal brain imaging and neurodevelopmental comorbidity as analysed in our previous systematic review and meta-analysis. The additional outcomes of abnormal antenatal brain imaging and neonatal death (NND) were also examined. This review has allowed inclusion of the recent literature informing clinical practice to aid counselling patients and highlight areas of future research.
Methods
The systematic review was performed according to an a priori protocol and complied with recommended guidance including the 'Meta-analyses and systematic reviews Of Observational Studies' (MOOSE) and 'Preferred Reporting Items for Systematic reviews and Meta-Analyses' (PRISMA) guidelines.
14,15 Ethical approval was not required. F.L.M. is funded by the Richard and Jack Wiseman Trust but the Trust had no involvement in study.
Eligibility criteria
Studies must have included at least five cases of sIUFD in twin pregnancies, and the gestation of the initial sIUFD must have been after 14 weeks. Twin chorionicity had to be defined but studies did not have to include both MC and DC twin pregnancies in the same study. Studies were excluded if the following conditions could not be abstracted for analysis: selective termination, higher order multiple pregnancies, twin reversed arterial perfusion (TRAP) sequence, structural or chromosomal anomalies, conjoined twins, monoamniotic twins or first-trimester miscarriages associated with twins. As the aim of the study was to assess spontaneous IUFD, those which occurred following an intervention for TTTS or sFGR, including fetoscopic laser ablation (FLA) or bilateral cord occlusion (BCO), were not included in the analysis, as there are confounding factors that may affect the outcome of the pregnancy, including surgeon experience, which make this group heterogeneous. 13 Amniodrainage was not considered an intervention that affects co-twin prognosis, as the main reason for IUFD following amniodrainage is likely due to TTTS itself, rather than a complication of the amniodrainage; therefore these pregnancies were kept in the analysis.
Outcomes
There is no core outcome set for multiple pregnancy, particularly sIUFD co-twin survivors, and patients were not involved in the development of the research, thus the outcomes assessed were the outcomes in the previous review, with the addition of antenatal brain imaging and NND. The outcomes were defined a priori as:
Co-twin intrauterine fetal death, greater than 14 weeks' gestation but prior to delivery. PTB, defined as a live birth of the surviving co-twin, irrespective of whether the birth was spontaneous or iatrogenic, which will be explored as a sub-group analysis, between 24 +0 and 34 +0 weeks' gestation as some monochorionic diamniotic twins are routinely delivered at less than 36 weeks, and with few long-term consequences.
Abnormal antenatal brain imaging. There was no limit on timing of imaging post-IUFD or type of imaging, as no consensus guidance existed at the time of this review. Abnormal postnatal brain imaging. There was no limit on imaging modality. Neurodevelopmental comorbidity was defined as per study, as there is no standard test to assess this in sIUFD. NND, defined as death within 28 days of live birth.
Information sources
The search was performed according to previously published methods. 6 In brief, Medline, Embase, Web of Science, Cochrane Library, and British Nursing Index were searched. Due to the inclusion of the new outcomes of abnormal antenatal brain imaging, and NND, the searches were run from 1980, because of the introduction of ultrasound into clinical practice, to 9 June 2017.
Search strategy
Keywords and variants of 'intrauterine', 'death', and 'twin' were used (see Supporting Information Appendix S1 for search strategy). Bibliographies were manually checked and there was no restriction on language.
Study selection and data extraction F.L.M., A.R., and R.K.M. independently extracted the data needed to assess the quality of the studies and form a 2 9 2 contingency table, using piloted data collection forms. Data from the previous systematic review by Hillman 6 was re-extracted by F.L.M. and R.K.M. Any discrepancies were resolved by M.D.K. If clarification was required, authors were contacted.
Quality assessment of included studies
The quality of the studies was assessed according to the 'Strengthening the Reporting of Observational studies in Epidemiology' (STROBE) checklist. 16 
Assessment of heterogeneity
Heterogeneity between the studies was assessed visually using forest plots and statistically using the I 2 statistic. An I 2 statistic ≥50% indicated a high-risk of heterogeneity. Heterogeneity was investigated via sub-group and sensitivity analysis.
Assessment of reporting bias
If >10 studies were included in a meta-analysis, a funnel plot was generated in STATA (Stata, 2015 Release 13.1; StataCorp, College Station, TX, USA) and Egger's test was performed with P < 0.05 considered a significant risk of small-study effects publication bias.
Data synthesis
With the additional 20 studies, we have produced a summary event rate statistic which has allowed for the nonindependence of different studies when the data are pooled, as is appropriate in a meta-analysis. Odds ratios (ORs) with random effects were calculated to compare the risk in MC twin pregnancies with DC twin pregnancies; 0.5 was added to 0 cells in all analyses to allow inclusion of more studies. 17 If a study only included MC twin pregnancies, the study was used to calculate the summary event rate for MC twins only and was not included in the DC summary event rate or OR calculation of MC versus DC twins, and vice versa if a study only included DC twin pregnancies. Sub-group analysis, in analyses of ≥3 studies, was planned to evaluate the effect of factors identified as potential causes of heterogeneity prior to commencing analysis: gestational age of sIUFD less than 28 weeks, TTTS (managed conservatively, meaning no intervention but continued surveillance), FGR (managed conservatively), year of publication pre-and post-2011. Twenty-eight weeks was chosen as a cut-off to distinguish between trimesters, as there is no research to determine an evidence-based cut-off. PTB as an outcome was also divided into iatrogenic and spontaneous where possible. Antenatal and postnatal brain imaging were divided by imaging modality, and the postnatal outcomes were also divided by PTB where possible, the latter irrespective of whether the PTB was iatrogenic or spontaneous. The sub-group summary event rate was reported as the rate of the outcome (e.g. co-twin IUFD) in women with or without that factor (e.g. sIUFD at less than 28 weeks, TTTS, FGR) to enable maximum clinical utility for counselling women in each scenario. ORs were calculated to compare the summary event rate for each factor in MC and DC twin pregnancies.
Results

Study selection and characteristics
The search revealed 2966 citations potentially eligible for inclusion, of which 2629 were excluded on the title or abstract, 337 complete manuscripts were assessed, and 42 full papers were eligible for inclusion 2, 3, (Supporting Information Figure S1 ). The characteristics of the included studies are described in Table S1 , which summarises the study design, study population, and details of abnormal brain imaging and neurodevelopmental comorbidity. The previous review included 22 studies. 2, 19, 20, 22, 26, 28, 30, 32, 34, 35, 37, [41] [42] [43] 47, 49, 50, 52, 54, 55, 57, 58 Of the 42 studies, 39 were included in the meta-analysis (for details of excluded studies see Supporting Information Appendix S2). The additional outcomes of antenatal brain imaging and NND were reported by six studies and 19 studies, respectively. The imaging modalities used were ultrasound and fetal magnetic resonance imaging (fMRI) antenatally; CT scan was also used postnatally.
Risk of bias of included studies
The quality of the included studies is displayed in Figure 1 . All the studies reported study design and the number of outcome events. None of the studies explained how their sample size was determined. The number of participants at each stage of the study was reported in 20/42 (47.6%) studies, so there may have been selective reporting in some studies. Only 15/42 (35.7%) studies reported which data were missing, and 19/42 (45.2%) adequately reported the limitations of their study. When there were fewer than ten studies and Egger's test was performed, the results are reported below with each outcome, as some analyses suggested small-study effects.
Synthesis of results
Summary event rates
The co-twin survivor in MC twin pregnancies was at significantly higher risk of co-twin IUFD (Table 1, Figure 2 ; additional forest plots and extracted 2 9 2 data are shown in Supporting Information Appendix S3) and abnormal postnatal brain imaging compared with co-twin survivors in DC twin pregnancies. No significant difference was found between MC and DC twin pregnancies in the rate of PTB, neurodevelopmental comorbidity or NND, although the latter outcome was borderline significant. The rate of abnormal antenatal brain imaging in MC twin pregnancies was 20%, but as no studies were found reporting this outcome in DC twin pregnancies, the OR was not calculated. The abnormal brain imaging findings included: intraventricular haemorrhage, periventricular haemorrhage, focal infarction, extensive encephalomalacia, poor sulcation, and abnormal cortex consistent with extensive reparative polymicrogyria.
Sub-group
Sub-group analysis demonstrated that in MC twin pregnancies, those with an sIUFD at less than 28 weeks were significantly more likely to have a co-twin IUFD than those with an sIUFD at 28 weeks or more. The pathologies of TTTS and FGR were not associated with an increased risk of co-twin IUFD (Table 2) . Pregnancies complicated by TTTS were significantly more likely to have a PTB compared with twin pregnancies without TTTS. When PTB was divided according to whether it was iatrogenic or spontaneous, in MC twins the summary event rate of iatrogenic PTB was 60.4% (95% CI 33.5-109.1, I 2 = 0.0%, three studies, seven pregnancies) compared with a spontaneous PTB rate of 37.1% (95% CI 20.5-66.9, I 2 = 24.1%, three studies, four pregnancies). There were no significant sub-group results for abnormal postnatal brain imaging or neurodevelopmental comorbidity in MC twins, and it was not possible to perform sub-group analysis for the abnormal antenatal brain imaging, as often this information was not included in the primary full manuscripts. In DC twins the summary event rate of iatrogenic PTB was 32.4% (95% CI 14.6-72.1, I 2 = 32.7%, three studies, six pregnancies) compared with a spontaneous PTB rate of 70.7% (95% CI 31.8-157.4, I 2 = 0.0%, three studies, six pregnancies), although the wide 95% CIs should be noted, which may be due to small sample size. Other sub-group analysis in DC twins was limited due to small numbers PTB, but the following analyses were possible, none of which found a significant difference: sIUFD at less than 28 weeks did not affect co-twin IUFD, PTB, abnormal postnatal brain imaging, neurodevelopmental comorbidity or NND; FGR did not affect co-twin IUFD or PTB, neurodevelopmental comorbidity or NND; PTB did not affect abnormal postnatal brain imaging, neurodevelopmental comorbidity or NND.
All six MC twin pregnancy studies which reported antenatal brain imaging compared fMRI with fetal ultrasound in the same pregnancy. 18, 26, 29, 38, 46, 48 Ultrasound 'missed' 6/19 (31.5%) lesions detected on fMRI in three studies 29, 38, 46 and the other three studies demonstrated concordance between the two imaging modalities, 18, 26, 48 although this difference was not statistically significant. In abnormal postnatal brain imaging, it was not possible to perform sub-group analysis based on the imaging modalities of MRI or CT scan, as two studies used ultrasound and MRI, 43, 48 one study used ultrasound and CT, 32 and two studies did not state the mode of imaging. 31, 44 The rate of NND was higher in MC twin pregnancies where the initial sIUFD occurred at less than 28 weeks' gestation, in those with FGR, and those with PTB. No factors affected the risk of adverse outcome in DC twin survivors. It was not possible to calculate ORs for the year of publication sub-group analysis.
Publication bias
The funnel plots for co-twin IUFD, PTB, abnormal postnatal brain imaging, and neurodevelopmental comorbidity appear asymmetrical, and Egger's test suggests small-study effects such as publication bias may exist in MC and the DC twins (funnel plots available from authors on request). 
Discussion
Main findings
Abnormal antenatal brain imaging following sIUFD has not previously been meta-analysed; we report a rate of one in five surviving MC co-twins demonstrating abnormal brain imaging, which doubled on postnatal brain imaging. NND was another novel outcome in our review; almost three in 10 liveborn MC co-twins die in the neonatal period, and two in 10 DC co-twins. In MC twins, if the initial sIUFD occurred at less than 28 weeks' gestation, this significantly increased the rate of co-twin IUFD and NND compared with pregnancies in which the initial sIUFD occurred at more than 28 weeks. The presence of TTTS was associated with a significant increase in the rate of PTB, but no other adverse outcome.
Strength and limitations
This systematic review provides clinicians and parents with the most up-to-date rates of complications in the surviving twin following spontaneous sIUFD as reported by the literature. It also allows more tailored counselling, for example, depending on the gestation of the initial sIUFD. According to international guidance, [7] [8] [9] [10] [11] [12] MC twins should be scanned at a minimum frequency of every 2 weeks, and DC twins every 4 weeks; it is therefore possible that some cases of co-twin IUFD have been missed by studies, as there may appear to be a double IUFD at the subsequent ultrasound scan, although the surviving co-twin may have been alive for a substantial period following the initial sIUFD. Some of the sub-group analysis was limited because these data were not reported by the included studies. For example, it was not possible to perform the sub-group analysis based on year of publication, thus the inclusion of older studies with different antenatal care guidance and neonatal care provision may increase the risk of heterogeneity. Ideally, for the PTB outcome, we would have performed further analysis using cut-offs of 24-28, 28-32 weeks, etc., as our definition of less than 34 weeks was somewhat crude; however, there were insufficient numbers of pregnancies to do this. It would also be more clinically useful if the gestation of sIUFD could be more specific than before or after 28 weeks, but this would require individual patient data. There was a myriad of differences between studies reporting brain imaging findings, including different referral criteria, different timing of antenatal imaging varying from 0 to 12 weeks post-IUFD, different imaging modalities, antenatal imaging findings were rarely linked to postnatal imaging findings and neurodevelopmental comorbidity, follow up was poor, and no studies were found reporting antenatal brain imaging in DC twins. Different methods of assessing neurodevelopment were used, making interpretation difficult. The results of this meta-analysis are not applicable to 
Interpretation
When co-twin IUFD is viewed in the context of the summary event rates, the rate appears higher in both MC and DC twins compared with our previous review. We advise caution when interpreting this result as it is may be an overestimate. This may be due to the existence of smallstudy effects, such as publication bias in this outcome, and it is likely that there is selection bias, as authors are more likely to report adverse outcomes than normal outcomes. Nevertheless, these event rates are the most recent data available and 10 additional studies have been published since the previous review. The smaller 95% CI when comparing co-twin IUFD between chorionicities suggests that the most recent results are more realistic, and the increased rate seen in MC twins compared with DC twins is to be expected given the presence of vascular anastomoses in the former. The significant difference may also be a consequence of an improved ability to determine chorionicity, better knowledge, and changes in monitoring over time.
The lack of difference in adverse outcomes, including cotwin IUFD, in TTTS pregnancies may be because of excluding TTTS pregnancies undergoing FLA or BCO, thus there was a higher proportion of milder cases of TTTS. This was different from the previous review but as the treatment for TTTS has advanced dramatically, its use is more widespread since 2011, and there are different confounding factors in comparison with spontaneous sIUFD, it was important to include this restriction. TTTS was associated with an increased PTB rate, although it was not possible to determine whether they were spontaneous or iatrogenic.
No difference was found in PTB between MC and DC surviving co-twins, suggesting that the mechanism of PTB in these cases is not inherent to chorionicity or vascular anastomoses but rather to factors common to all twin pregnancies. With regard to abnormal antenatal and postnatal brain imaging, these results are difficult to interpret for the reasons previously outlined. The higher rate of abnormal postnatal brain imaging in MC twins compared with DC twins was expected, as it is believed that when one MC twin dies, acute transfusional events through inter-twin placental anastomoses occur, as reviewed by Mackie et al., 59 resulting in cerebral injury detectable on postnatal brain imaging in the surviving co-twin. In contrast, in DC twins the cause of the cerebral pathology is more likely a result of the pathological condition which killed the other twin, rather than a consequence of the sIUFD. The similarity between chorionicities and sub-group analysis in the neurodevelopmental comorbidity outcome may be due to small study size, or be a reflection of there being no difference in PTB between the chorionicities. The borderline significant higher rate of NND in MC twins compared with DC twins was to be expected, in particular, if the initial sIUFD was less than 28 weeks, or FGR or PTB was involved, the rate of NND was significantly higher in MC twins. It would be interesting to explore the relation between these factors further, but it was not possible here.
Conclusion
Our results will help clinicians counsel parents with a sIUFD and give information based upon chorionicity. The high rate of adverse outcomes highlights the importance of close antenatal surveillance, particularly in MC surviving co-twins, and those in which the sIUFD has occurred at <28 weeks. PTB was the commonest adverse outcome and clinicians and parents should be aware of the high risk of PTB in these pregnancies, and the potential requirement of neonatal unit admission. Outcomes regarding brain imaging and neurodevelopmental comorbidity are an important area for future research as this outcome is important to parents and will affect the quality of life of not only the surviving twin, but also other family members. The high rate of 20% of co-twins with an abnormal antenatal fMRI highlights that parents should always be offered antenatal brain imaging. In line with our findings, and those of the MERIDIAN study, the imaging modality should be fMRI not ultrasound. 60 A study is needed examining antenatal and postnatal brain imaging and neurodevelopmental comorbidity in the same surviving co-twins, in a standardised manner, with adequate follow-up. The studies included in this meta-analysis were small and small study effects were shown to exist, consequently, the authors have recognised the need to perform a large population-based study and are in the process of conducting a study using data from the UK Obstetric Surveillance Survey (UKOSS). This will be the largest study of complications in the surviving co-twin in a population cared for using the same national guidance (for further details see 61 ).
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